Toxicology Lab Billing Services

Toxicology lab billing gets scrutiny from payers. Drug testing can mean many analytes per sample, and payers have long watched for testing that does not match a patient's clinical need. Labs that cannot show why a test was ordered often face denials, recoupments, or audits.

The work also depends on getting test type right. Presumptive tests screen for drug classes. Definitive tests identify and measure specific drugs. Each has its own codes, limits, and documentation needs, and payers often differ. Westmont connects toxicology and drug testing labs with vetted billing experts who understand these distinctions, help manage clinical documentation gaps, and keep claims defensible.

Who this is for

• Independent toxicology and drug testing laboratories
• Labs serving addiction treatment and recovery programs
• Labs supporting pain management and primary care clients
• Labs serving behavioral health and substance use disorder programs
• Hospital outreach labs that run drug testing
• New labs that need payer enrollment help

What gets billed

• Presumptive urine drug screens, by cup or instrument
• Definitive drug identification and quantification testing
• Medication monitoring for patients on long-term therapy
• Confirmation testing after a positive screen
• Specimen validity testing in some settings
• Oral fluid and other specimen types where payers allow
• Specimen collection and handling fees where separately payable
• Point-of-care drug screens run under a CLIA certificate

Commonly billed codes

Code	Type	What it covers
80305	CPT	Presumptive drug class screen read by direct observation, such as a test cup
80306	CPT	Presumptive drug class screen read with an instrument
80307	CPT	Presumptive drug class screen run on an analyzer
G0480	HCPCS	Definitive drug testing, a small number of drug classes (Medicare)
G0481	HCPCS	Definitive drug testing, a moderate number of drug classes (Medicare)
G0482	HCPCS	Definitive drug testing, a larger number of drug classes (Medicare)
G0483	HCPCS	Definitive drug testing, the largest group of drug classes (Medicare)
Z79.891	ICD-10-CM	Long-term use of opioid pain medicine
F11.20	ICD-10-CM	Opioid dependence, without complications
Z51.81	ICD-10-CM	Encounter for drug level monitoring

Note

Codes are examples for orientation, not a complete list, and do not guarantee coverage or payment. Always check current code sets and payer policy.

Many commercial payers use CPT definitive codes in the 80320 to 80377 range instead of the G codes. Check each payer's policy.

Billing challenges in toxicology

• Presumptive versus definitive rules. Payers set limits on when definitive testing follows a screen. A toxicology biller maps each order to payer policy and flags tests that need documentation.
• Medical necessity. Policies often tie testing to the patient's risk level and treatment plan. Billers help set order forms that capture the clinical reason, not just a diagnosis code.
• Frequency limits. Many payers cap how often a patient can be tested in a period. Billers track history where they can and adjust billing to match limits.
• Drug class counting. Definitive codes depend on the number of classes tested. Counting errors can cause denials or overpayment. Billers verify the count against the test menu and report.
• Prepayment reviews and audits. Labs in this field see more reviews than most. Billers keep records ready, respond to records requests on time, and track findings to prevent repeats.
• Standing orders. Payers often reject testing based on standing or blanket orders. Billers help labs and clients move to documented, patient-specific orders.
• Reference lab and client relationships. Referral rules, such as anti-kickback and state laws, affect how labs can work with clients. Check with legal counsel. Billers keep billing practices consistent with your contracts.

How Westmont can help

• Match your lab with vetted billing experts experienced in toxicology and drug testing
• Support end-to-end revenue cycle work, from order intake to payment posting
• Help with denial management, appeals, and audit response
• Assist with payer enrollment and credentialing
• Review order forms and documentation habits that affect payment

Frequently asked questions

What is the difference between presumptive and definitive drug testing?

Presumptive tests are screens that suggest whether a drug class is present. Definitive tests identify specific drugs and often measure how much is present. Payers usually pay screens at lower levels and apply stricter rules to definitive tests. Your billing partner should know which policy applies to each order.

Why do payers deny toxicology claims so often?

Common reasons include testing that does not match the patient's documented risk, too many drug classes, tests run too often, and standing orders. Payers also review labs with high volume. Clear order forms and strong clinical notes from the ordering provider reduce risk.

Do I need a special modifier for drug screens?

Waived tests run on site may need QW for Medicare, and some payers use modifier 59 or similar when separate services are reported together. Rules differ by payer. Confirm each payer's policy and review claim edits before billing.

How do I handle a drug testing audit?

Respond on time, send complete records, and keep copies of what you submit. Records usually include the order, results, medical necessity notes from the ordering provider, and lab procedures. A billing expert can help organize the file. For legal questions, work with qualified counsel.

Can a toxicology lab bill patients directly?

Often yes, but rules depend on contracts, state law, and payer policy. Many labs bill insurance first. Some payers restrict patient billing after a denial. Review your agreements and have a billing expert set a clear, compliant process.

Related billing services

• Clinical & Reference Laboratory Billing
• Addiction Medicine Billing
• Pain Management Billing
• Pathology Billing
• Psychiatry Billing
• IOP and PHP Billing